1. Freeze, H.H. (2002) Human disorders in N- glycosylation and animal models. Bio-chim Biophys Acta 1573: 388–393.
2. Butler, M., Quelhas, D., Critchley, A.J., Carchon, H., Hebestreit, H.F., Hibbet, R.G., Vilarinho, L., Teles, E., Matthijs, G., Schollen, E., Argibay, P., Har vey, D.J., Dwek, R.A. and Rudd, P.M. (2003) Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. Glycobiology 13: 601–622.
3. Axford, J.S., Cunnane, G., Fitzgerald, O., Bresnihan, B. and Frears, E.R. (2003) Rheumatic disease differentiation using immunoglobulin G sugar printing by high-density electrophoresis. J Rheumatol 12: 2540–2546.
4. Youings, A., Chang, S.C., Dwek, R.A. and Scragg, I.G. (1996) Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Bio-chem J 314: 621–630.
5. Holland, M., Yagi, H., Takahashi, N., Kato, K., Savage, C.O.S., Goodall, D.M. and Jefferis, R. (2006) Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA associated systemic vasculitis. Biochim Biophys Acta 1760: 669–677.